Gene Discovery and Biological Insights into Anxiety Disorders from a Multi-Ancestry Genome-wide Association Study of >1.2 Million Participants.
Eleni FriligkouSolveig LøkhammerBrenda Cabrera-MendozaJie ShenJun HeGiovanni DeianaMihaela Diana ZanoagaZeynep AsgelAbigail PilcherLuciana Di LascioAna MakharashviliDora KollerDaniel S TyleeGita A PathakRenato PolimantiPublished in: medRxiv : the preprint server for health sciences (2024)
We leveraged information from more than 1.2 million participants to investigate the genetics of anxiety disorders across five continental ancestral groups. Ancestry-specific and cross-ancestry genome-wide association studies identified 51 anxiety-associated loci, 39 of which are novel. Additionally, polygenic risk scores derived from individuals of European descent were associated with anxiety in African, Admixed-American, and East Asian groups. The heritability of anxiety was enriched for genes expressed in the limbic system, the cerebral cortex, the cerebellum, the metencephalon, the entorhinal cortex, and the brain stem. Transcriptome- and proteome-wide analyses highlighted 115 genes associated with anxiety through brain-specific and cross-tissue regulation. We also observed global and local genetic correlations with depression, schizophrenia, and bipolar disorder and putative causal relationships with several physical health conditions. Overall, this study expands the knowledge regarding the genetic risk and pathogenesis of anxiety disorders, highlighting the importance of investigating diverse populations and integrating multi-omics information.
Keyphrases
- genome wide association study
- genome wide
- bipolar disorder
- sleep quality
- genome wide association
- resting state
- functional connectivity
- healthcare
- dna methylation
- copy number
- health information
- mental health
- white matter
- major depressive disorder
- cerebral ischemia
- multiple sclerosis
- genome wide identification
- high throughput
- climate change
- rna seq
- human health
- health promotion
- breast cancer risk